In a mouse model of pulmonary melanoma, MSCs were utilized to deliver an IL-15-carrying tumor-lytic MYXV construct, resulting in sustained viral presence and increased infiltration of NK cells and CD8+ T cells. This evidence concerns the gene CD8A and neoplasm.